Immunotherapy Study of Evofosfamide in Combination With Ipilimumab

Conditions:   Pancreatic Cancer;   Melanoma;   Squamous Cell Carcinoma of the Head and Neck;   Prostate Cancer
Interventions:   Drug: Evofosfamide;   Drug: Ipilimumab
Sponsors:   Threshold Pharmaceuticals;   M.D. Anderson Cancer Center
Not yet recruiting - verified March 2017

http://ift.tt/2ojEv1L